Using nitric oxide during heart surgery in newborns to prevent kidney injury
Official title: Efficacy of Nitric Oxide Administration During Cardiopulmonary Bypass in Neonates at Reducing the Risk of Acute Kidney Injury
Run by Children's Hospital Medical Center, Cincinnati · NCT04216927 · Data updated 2026-11-12
This study is testing if using nitric oxide during heart surgery can help newborns avoid kidney injury after their operation.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 1 Day to 31 Days |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Children's Hospital Medical Center, Cincinnati Academic / other |
| Locations | 1 site (Cincinnati, Ohio) |
| Status | Recruiting |
| Started | January 10, 2023 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | August 5, 2026 |
| Trial ID | NCT04216927 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are neonates aged 31 days or younger who are scheduled for cardiac surgery involving cardiopulmonary bypass.
✕Probably not a fit
Patients with pre-existing kidney issues, major congenital anomalies, or those requiring emergency surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the use of nitric oxide during cardiopulmonary bypass in neonates undergoing cardiac surgery for congenital heart disease. The study aims to determine if administering nitric oxide can reduce the incidence of acute kidney injury, a common complication affecting up to 60% of high-risk patients post-surgery. By targeting the inflammatory and coagulation pathways, the researchers hope to improve renal outcomes in this vulnerable population. The trial is interventional and is currently in Phase 3.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of acute kidney injury in neonates undergoing cardiac surgery.
How similar studies have gone: While the use of nitric oxide in similar contexts has shown promise, this specific approach in neonates undergoing cardiac surgery is novel and has not been widely tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All neonates (≤31 days) undergoing cardiac surgery with CPB for CHD will be deemed eligible for enrollment. Exclusion Criteria: 1. Failure to obtain informed consent from parent/guardian 2. Clinical signs of preoperative persistent elevated pulmonary vascular resistance, 3. Emergency surgery, 4. Episode of cardiac arrest within 1 week before surgery, 5. Recent treatment with steroids and/or a condition that may require treatment with steroids (excluding steroid administration specifically for CPB), 6. Use of inhaled NO (iNO) immediately prior to surgery, 7. Structural renal abnormalities by ultrasound, 8. Preoperative AKI, 9. Use of other investigational drugs, 10. Weight less than \<2 kg, 11. Gestational age \<36 weeks, 12. Major extracardiac congenital anomalies, 13. Non-English speakers.
Where it's running
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States Recruiting
Study contacts
- Study coordinator: David S Cooepr, MD
- Email: David.Cooper@cchmc.org
- Phone: 5138035448
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Abdomen-based pulse oximeter for babies with congenital heart disease
This study tests whether a belly-worn pulse oximeter works as well as a traditional fingertip device in babies with complex heart conditions.
-
Epidemiology and care for dialysis in ICU patients with severe acute kidney injury in Latin America
This project will collect and compare data on adults in ICUs across Latin America who need dialysis for severe acute kidney injury to see how they are treated and what outcomes they have.
-
Ultrafast ultrasound imaging for congenital heart disease in children
This project will try ultrafast ultrasound to measure heart muscle stiffness and blood flow in children with congenital heart disease.
-
Outpatient recovery after acute kidney injury that required dialysis
This pilot will test whether measuring residual kidney function at hospital discharge and sharing that information with patients and their outpatient nephrologists, plus guidance on monitoring and considering twice-weekly dialysis, helps adults who had acute kidney injury and still need dialysis after leaving the hospi
-
Bilateral superficial parasternal intercostal plane block vs erector spinae plane block for heart surgery
In children with congenital heart disease, this study tests whether two ultrasound-guided nerve blocks used with fentanyl can better control pain after heart surgery than the other block.
-
Evaluating the role of genetics in kidney disease progression
This study is trying to see how genetics affects the worsening of kidney diseases like acute kidney injury and chronic kidney disease in people, especially those with high blood pressure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.